The aim of this study was to analyse the efficacy of levothyroxine (LT4) treatment to normalise thyroid hormone levels in thyroid cancer patients with increased thyroid-stimulating hormone (TSH) after TKI initiation. The gene discussed is TG; the disease is thyroid gland carcinoma.